Last reviewed · How we verify
Cholera vaccination
At a glance
| Generic name | Cholera vaccination |
|---|---|
| Also known as | Dukoral |
| Sponsor | NIZO Food Research |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Extended Dosing Intervals Trial for Oral Cholera Vaccine, Kenya (PHASE4)
- Immunologic Responses to a Live Attenuated Oral Cholera Vaccine (PHASE2)
- CVD 38000: Study of Responses to Vaccination With Typhoid and/or Cholera (PHASE4)
- Immune Response Elicited by Concomitant Administration of Oral Typhoid Fever (Vivotif®) and Cholera (Dukoral®) Vaccines (PHASE4)
- Impact Study of Cholera Vaccination in Endemic Areas - Seroprevalence
- Impact Study of Cholera Vaccination in Endemic Areas - Clinical Surveillance
- Follow-up of Pregnant Women After a Mass Vaccination of Oral Cholera Vaccine (ShancholTM) in Nsanje Malawi (NA)
- Safety and Efficacy Challenge Study of Live Oral Cholera Vaccine Candidate,PXVX0200, to Prevent Cholera (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |